Broadcom Extends Apple Chip Supply Deal Through 2031

What happened

Broadcom extended its chip supply agreement with Apple through 2031, securing a critical source of wireless and RF chip revenue that accounted for a significant portion of its Semiconductor Solutions segment. The deal reduces customer concentration risk, as Apple has historically been a large indirect customer, but the core investment thesis remains unchanged. Broadcom's future still hinges on successfully ramping custom AI accelerators to $56B in FY2026 and achieving over $100B in FY2027, as outlined in its Q2 FY2026 filings. VMware's recurring revenue stability and risks from EU antitrust scrutiny and the AI rack leasing backstop exposure remain key uncertainties. At $372, the stock's elevated valuation leaves no room for execution missteps, despite this positive news.

Implication

The extension locks in a key customer relationship, lowering the risk of a sudden revenue drop from Apple's wireless segment, which had been an overhang. However, the Apple business is mature and lower-growth relative to the AI opportunity, so this news alone does not materially alter Broadcom's growth trajectory. The primary value driver remains the custom AI accelerator ramp, which must deliver on aggressive FY2026 and FY2027 targets. Given the stock's high multiples (60x P/E), any disappointment in AI revenue or VMware retention could trigger a de-rating. Investors should maintain a wait-and-see approach until Q3 results confirm the AI step-up and RPO stability.

Thesis delta

The Apple deal extension provides incremental revenue visibility and reduces one tail risk, but the core thesis remains unchanged. The main uncertainties around AI ramp execution, VMware churn, and EU regulatory action persist. This news does not shift the WAIT rating or the attractive entry price of $330.